Braeburn

About Braeburn

Braeburn is a biopharmaceutical company dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder. We are dedicated to advancing a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of addiction faced by patients, healthcare professionals, payers and society.

Braeburn has one mission: to fight the opioid addiction epidemic. The work we are doing can make a difference in the lives of patients who often shoulder the burden of treatment themselves. We aim to reduce stigma by raising awareness that OUD is a chronic brain disease best treated by evidence-based medication-assisted treatment.

We are dedicated to developing into a highly effective organization; and through collaboration and commitment we can execute on our mission. Our operating principles define how we work together to achieve our goals:

· Communicate directly, in an open and honest manner

· Honor our commitments

· Ask challenging questions

· Assume positive intent

· Listen and understand

· Support and invest in each other's development

For more information about Braeburn, please visit www.braeburnrx.com.